LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,277,151 | -21.1% | 1,344,010 | -18.9% | 0.02% | -18.2% |
| Q2 2023 | $114,441,454 | +35.0% | 1,657,851 | -5.7% | 0.02% | +29.4% |
| Q1 2023 | $84,743,177 | -6.4% | 1,757,428 | -3.1% | 0.02% | -5.6% |
| Q4 2022 | $90,492,479 | +34.2% | 1,812,750 | +9.7% | 0.02% | +28.6% |
| Q3 2022 | $67,442,000 | -53.0% | 1,652,965 | -36.6% | 0.01% | -51.7% |
| Q2 2022 | $143,468,000 | +51.3% | 2,608,488 | -0.1% | 0.03% | +81.2% |
| Q1 2022 | $94,841,000 | -10.6% | 2,609,818 | +14.6% | 0.02% | -5.9% |
| Q4 2021 | $106,134,000 | +254.2% | 2,277,045 | +284.2% | 0.02% | +240.0% |
| Q3 2021 | $29,964,000 | +127.6% | 592,635 | +39.0% | 0.01% | +66.7% |
| Q3 2020 | $13,166,000 | -50.0% | 426,484 | -31.0% | 0.00% | -50.0% |
| Q2 2020 | $26,310,000 | – | 618,223 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |